Deregulation of LOXL1-AS1 has also been reported in some types of other cancer such as pancreatic cancer, osteosarcoma, medulloblastoma, choriocarcinoma, retinoblastoma, thymoma and thymic carcinoma and renal cell carcinoma (RCC) (23, 32, 98–102). This evidence concerns the gene LOXL1 and renal cell carcinoma.